Letter by Garcia-Moll Regarding Article, â•œGlycemic Control Status After Percutaneous Coronary Intervention and Long-Term C
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials
Ramberättelse AN
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study | PLOS Medicine
SAS Nordic
ESC Heart Failure: Vol 9, No 5
FUBUKI | Stockholm
Diagnostics | Free Full-Text | Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients
Coronary Wave Intensity Analysis as an Invasive and Vessel-Specific Index of Myocardial Viability | Circulation: Cardiovascular Interventions
IJMS | Free Full-Text | Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Optimization Of Insulin Therapy In Patients With Type 2 Diabetes - Endocrine Practice
Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis | Arteriosclerosis, Thrombosis, and Vascular Biology
Henrik Eriksson on LinkedIn: #greatresignation #greatrenegotiation
Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile
Hospital Insulin Protocol Aims For Glucose Control In Glucocorticoid-Induced Hyperglycemia - Endocrine Practice
JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink
IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
Untitled
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes
Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association
Frontiers | Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury
FUBUKI | Stockholm
JCM | Free Full-Text | The Link between Stroke Risk and Orodental Status—A Comprehensive Review
Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure | Scientific Reports
Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis - Kastora - 2022 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
